QuantumPharm, a prominent company in the pharmaceutical industry, saw its shares surge by an impressive 8.22% on October 18, 2024, following an announcement of a proposed name change.
According to a filing with the Hong Kong bourse on Friday, QuantumPharm intends to change its name to XtalPi Holdings, subject to approval from shareholders and the relevant authorities in the Cayman Islands, where the company is incorporated.
The news of the impending name change appears to have been well-received by investors, as the company's stock price closed nearly 8% higher at the end of Friday's trading session, reflecting the market's positive sentiment towards this strategic move.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.